Non-QM delinquencies stabilizing across recent vintages

Just four years ago, the data center industry was abandoning public markets. Beginning with Blackstone’s $10B acquisition of QTS in 2021, a run of take-private deals swept the sector as CyrusOne, CoreSite and Switch all subsequently disappeared from public exchanges over the following months. By 2022, the number of listed data center firms had dwindled…

Enquiries from second- and third-steppers for new-build properties rose by 23% during the first six months of 2026, compared to the previous six months. The analysis from the new-build portal, Newhomesforsale, based on 58,000 homeowner enquiries indicated a growing interest in new-build homes among existing homeowners. The increase in interest from second- and third-steppers…

On its third-quarter 2026 earnings call, held on Oct. 27, 2026, Pulmonx (NASDAQ:LUNG) returned to year-over-year top-line growth with total revenue of $22.8 million. Commercial realignments and expense controls are narrowing losses while expanding the reach of its medical devices for severe lung disease. Three management statements highlight the drivers behind this financial turn. Pulmonx…

Shares of AbbVie, Eli Lilly and Gilead Sciences are trading at or near record highs.

October home sale prices post first annual decline in three years – Scotsman Guide Skip to content error: Content is protected !! This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We may also share information about your use of our site with our social…

2026 is emerging as a banner year for the S&P 500 (^GSPC -0.77%). Not necessarily for the index’s price growth, which is up 12.6% year-to-date, but because of its earnings growth. Analysts now expect S&P 500 earnings per share to grow 24%-32% this year, paced by blockbuster growth from AI stocks and the Magnificent Seven,…